Brown Forman vs Boston Beer
BF.B and SAM side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BF.B and SAM compare
Brown Forman is the larger company, worth 6.4 times as much as Boston Beer ($14.1B against $2.2B).
Brown Forman grew revenue faster over the last twelve months (−0.84% versus −3.7% for Boston Beer).
Brown Forman keeps more of each dollar of sales as profit, with a net margin of 18.4% compared with −3.8% at Boston Beer.
Brown Forman pays a dividend yielding 3.0%; Boston Beer does not pay one.
Brown Forman scores higher on the StockData Score (17 against 9 for Boston Beer), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BF.B | SAM |
|---|---|---|
| Size and price | ||
| Market cap | $14.1B | $2.2B |
| Share price | $30.82 | $219.16 |
| Change, 1 year | 15.9% | 8.9% |
| Change, 5 years | −59.0% | −52.8% |
| Beta (5Y) | 0.58 | 0.74 |
| Employees | 4,900 | 2,543 |
| StockData Score | ||
| Total score | 17 (better) | 9 |
| Valuation score | 4 (better) | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 4 (better) | 0 |
| Health score | 5 | 6 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 19.9× | – |
| P/S | 3.6× | 1.2× (better) |
| P/B | 3.6× | 3.0× (better) |
| EV/EBITDA | 15.0× | – |
| P/FCF | 15.3× | 12.0× (better) |
| FCF yield | 6.5% | 8.3% (better) |
| Fair value | $36.78 | $260.56 |
| Margin of safety | 16.2% (better) | 15.9% |
| Growth | ||
| Revenue growth (TTM) | −0.84% (better) | −3.7% |
| Revenue growth, 5Y average | 2.6% (better) | 2.5% |
| Net income growth (TTM) | −14.6% (better) | −179% |
| EPS growth (TTM) | −13.4% (better) | −181% |
| EPS growth, 5Y average | −4.0% (better) | −8.6% |
| Profitability | ||
| Gross margin | 60.7% (better) | 49.1% |
| Operating margin | 25.4% (better) | −5.1% |
| Net margin | 18.4% (better) | −3.8% |
| FCF margin | 23.6% (better) | 9.7% |
| Return on equity | 18.1% (better) | −8.9% |
| Return on invested capital | 13.0% (better) | −14.0% |
| Financial health | ||
| Debt / equity | 0.62 (better) | 0.00 |
| Net debt / EBITDA | 1.97 | – |
| Interest coverage | 9.6× | – |
| Current ratio | 3.26 (better) | 1.13 |
| Altman Z-score | 4.43 (better) | 4.02 |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.0% | – |
| Payout ratio | 59.1% | – |
| Years of dividend growth | 3 | – |
| Dividend growth, 5Y average | 5.3% | – |
| Buyback yield | – | 5.6% |
| Shareholder yield | 3.0% | 5.6% (better) |
| Ownership | ||
| Held by institutions | 47.6% | 85.1% |
| Held by insiders | 25.2% | 25.8% |
| Insider net buying, 12 months | −$1.5M | $0 (better) |
| Superinvestors holding | 3 (better) | 1 |
| Short interest, % of float | – | 21.4% |
Go deeper
- BF.B stock overview
- BF.B income statement
- BF.B valuation and score
- SAM stock overview
- SAM income statement
- SAM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.